Use of sulfomucopolysaccharides in the treatment of Alzheimer-ty

Details Use of sulfomucopolysaccharides in the treatment of Alzheimer-ty Use of sulfomucopolysaccharides in the treatment of Alzheimer-ty

1988-05-23

1990-09-11

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

A61K 31715, A61K 31725

Patent

active

049563475

ABSTRACT:
The administration of ateroid alleviates the symptoms of Alzheimer-type senile dementia.

REFERENCES:
patent: 3000787 (1961-09-01), Bianchini et al.
patent: 3007787 (1961-12-01), Campbell et al.
The Merck Manual, 14th Edition, 1982, pp. 1305-1309; "Dementia", Whole Article.

Affiliated with

Also associated with

Rating

Use of sulfomucopolysaccharides in the treatment of Alzheimer-ty does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of sulfomucopolysaccharides in the treatment of Alzheimer-ty, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sulfomucopolysaccharides in the treatment of Alzheimer-ty will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1184888